CXCR
Chemokine receptors are classified into four subgroups, the CC chemokine receptors (CCRs), CXCRs, XCRs and CX3-CRs. In humans, 18 chemokine receptors, comprising 10 CCRs, 6CXCRs, 1 XCR, and 1 CX3CR, have been characterised and act as receptors for at least 44 chemokine ligands. The CXC receptor 1 and 2 (CXCR1 and CXCR2) have been well characterised in vertebrates. In mammals and birds, the two receptors are shared by the ELR+ CXC ligands, namely the CXCL8 family members that have proinflammatory roles in recruitment of neutrophils, monocytes and macrophages to sites of infection. Activation of CXCR1 and CXCR2 leads to a cascade of cellular events responsible for migration, homeostasis and adhesion of the target cells. CXCR1 primarily binds with CXCL6–8 whilst CXCR2 is less ligand specific, interacting with almost all of the ELR+ CXC chemokines including CXCL1–3 and CXCL5–8. CXCR1 and CXCR2 recruit GRK2 and GRK6 respectively, to regulate leucocyte functions. This can lead to functional differences. CXCR2 but not CXCR1 is involved in CXCL8 mediated angiogenesis and cancer growth. CXCR3 is the sole receptor shared by three closely related ELR- chemokines CXCL9–11 and also interacts with CXCL4 and CCL21. CXCR4 has been discovered as a single copy gene in agnathan and gnathostome vertebrates except for teleosts where duplicated CXCR4 (CXCR4a and4b), and their ligands CXCL12 (CXCL12a and 12b), are present.
References
1.Zou J,et al. Gen Comp Endocrinol. 2015 May 1;215:117-31.
References
1.Zou J,et al. Gen Comp Endocrinol. 2015 May 1;215:117-31.
Autophagy
CXCR
-
FC131 TFA
产品货号 : M37915
cas no: 842166-42-1
FC131 TFA 是一种 CXCR4 拮抗剂,抑制 [125I]-SDF-1 与 CXCR4 结合,IC50 值为 4.5 nM。FC131 TFA 具有抗 HIV 的活性。 -
CXCL-CXCR1/2-IN-1
产品货号 : M37526
cas no: 2415653-55-1
CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer. -
Ulocuplumab
产品货号 : M36724
cas no: 1375830-34-4
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) 是一种完全人 IgG4 抗 CXCR4 抗体。Ulocplumab 诱导癌细胞凋亡 (apoptosis),能够抑制 CXCL12 介导的慢性淋巴细胞白血病 (CLL) 细胞在 CXCR4 激活下的迁移。Ulocplumab 在急性髓系白血病 (AML),非霍奇金淋巴瘤 (NHL) 和多发性骨髓瘤移植模型中显示抗肿瘤活性。 -
Mogamulizumab
产品货号 : M36717
cas no: 1159266-37-1
Mogamulizumab (KW-0761) 是一种重组 抗 CCR4 单克隆抗体 (MAb)。Mogamulizumab 可以通过抗体依赖性细胞毒性 (ADCC) 消除肿瘤细胞。Mogamulizumab 可用于癌症、成人T细胞白血病/淋巴瘤 (ATLL)、皮肤T细胞淋巴瘤 (CTCL) 的研究。 -
Eldelumab
产品货号 : M36693
cas no: 946414-98-8
Eldelumab (BMS-936557) 是一种人源化抗 CXCL10 (IP-10) 单克隆抗体 (IgG1型)。Eldelumab 可选择性地与 CXCL10 结合,并阻断 CXCL10 诱导的钙通量和细胞迁移。Eldelumab 可用于自身免疫和自身炎症性疾病 (如类风湿性关节炎、溃疡性结肠炎和克罗恩病) 的研究。